Pakistan Lashes Out at India’s ‘COVID Diplomacy’ After UN Hails New Delhi for Vaccine Exports

0
914

by Dhairya Maheshwari

Although India’s COVID diplomacy is winning accolades from other governments in the South Asia region, it has drawn criticism from New Delhi’s arch-rival, Islamabad, which has called upon Indian authorities to first focus on the healthcare facilities in Jammu and Kashmir, a major bone of contention between the two sides.

Pakistan has taken a critical view of the United Nations’ (UN) praise for India’s ongoing COVID diplomacy, as it alleged that the healthcare system in Jammu and Kashmir union territory (UT) was in a deplorable state, while Prime Minister Narendra Modi’s government continued to “flaunt” its diplomacy abroad.

“It is ironic that a country that continues to flaunt its so-called vaccine diplomacy abroad has turned hospitals in Jammu and Kashmir into graveyards, choking essential medical supplies, let alone the COVID vaccine”, Pakistan’s Permanent Representative to the UN Jawad Ali Chatha said at the General Assembly.

“It is ironic that a country that continues to flaunt its so-called #vaccine diplomacy abroad has turned hospitals in Occupied Jammu and Kashmir (IIOJK) into graveyards, choking essential medical supplies, let alone the Covid vaccine”: @jawadjac3284 #RoR #UNGA @UN @PakistanPR_UN pic.twitter.com/3iCP8O0k5n

— Permanent Mission of Pakistan to UN, NY 🇵🇰🇺🇳 (@PakistanUN_NY) January 29, 2021

Chatha was referring to some media reports on the poor state of the healthcare infrastructure in Jammu and Kashmir, which critics of New Delhi view as indifference of the federal government after the August 2019 decision to abrogate the semi-autonomous status of the region.

Both Pakistan and China, which claim part of the disputed Jammu and Kashmir region, have refused to recognise New Delhi’s August 2019 decision. On numerous occasions, India has categorically stated that Jammu and Kashmir is its “internal matter”.

The Pakistani diplomat’s reaction came in the wake of UN General Secretary Antonio Guterres’ remarks to the member states of the General Assembly.

“Our first priority for 2021 is to respond to COVID-19. Vaccines are the first great moral test before us… But the world is falling short”, Guterres said during his address, also expressing concern that vaccines were only reaching a handful of countries quickly.

Talking to reporters following his speech, the UN secretary general hailed India’s COVID production facility as an “asset for the world”.

Counting on India…

The production capacity of India is one of the best assets the world has today – @UN Secretary General#Covid19vaccine pic.twitter.com/Y8yosbHfZo

— Syed Akbaruddin (@AkbaruddinIndia) January 29, 2021

​”I think that the vaccine production capacity of India is the best asset that the world has today. I hope that the world understands that it must be fully used”, said Guterres.

India has so far exported millions of the domestically-manufactured COVID vaccine to countries in its neighbourhood.

“From 20 January 2021 onwards, we have gifted over 55 lakh (5.5 million) doses of vaccines to our neighbouring countries and in our extended neighbourhood – Bhutan (150,000), Maldives (100,000), Nepal (1 million), Bangladesh (2 million), Myanmar (1.5 million), Mauritius (100,000), Seychelles (50,000), Sri Lanka (500,000) and Bahrain (100,000). These supplies are based on requests from these countries”, India’s Foreign Ministry spokesperson Anurag Srivastava said at his weekly briefing on Thursday.

“Over the next few days, we plan to gift further quantities to Oman (100,000), CARICOM countries (500,000), Nicaragua (200,000) and Pacific Island states (200,000)”, the Indian official informed mediapersons.

The South Asian country is currently manufacturing two COVID vaccines at its production facilities — Covaxin, indigenously developed by the Indian pharmaceutical company Bharat Biotech, and Covishield, which has been jointly developed in the United Kingdom by the British-Swedish company AstraZeneca and the University of Oxford.

In India, Covishield is being manufactured by the Pune-based Serum Institute of India (SII).

Sputnik

LEAVE A REPLY

Please enter your comment!
Please enter your name here